A diagnostic study of Lymphoseek (technetium Tc 99m tilmanocept) to demonstrate the imaging time of sentinel lymph node in malignant melanoma compared to Tc99m sulfur colloid (SC).

Trial Profile

A diagnostic study of Lymphoseek (technetium Tc 99m tilmanocept) to demonstrate the imaging time of sentinel lymph node in malignant melanoma compared to Tc99m sulfur colloid (SC).

Completed
Phase of Trial: Phase II

Latest Information Update: 15 Dec 2015

At a glance

  • Drugs Tc 99m tilmanocept (Primary) ; Tc 99m sulfur colloid
  • Indications Malignant melanoma
  • Focus Diagnostic use
  • Most Recent Events

    • 15 Dec 2015 Status changed from not stated to completed.
    • 10 Dec 2015 New trial record
    • 03 Dec 2015 According to the Navidea Biopharmaceuticals Inc. media release, results were presented at the Radiological Society of North America Annual Meeting (RSNA 2015).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top